Business Description
Helius Medical Technologies Inc
NAICS : 325413
SIC : 3842
ISIN : US42328V5049
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 182.49 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.01 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -27.59 | |||||
Beneish M-Score | 0.52 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -66.2 | |||||
3-Year EBITDA Growth Rate | 67.5 | |||||
3-Year EPS without NRI Growth Rate | 68 | |||||
3-Year FCF Growth Rate | 67.3 | |||||
3-Year Book Growth Rate | -70.7 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 198.36 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -25.52 | |||||
12-1 Month Momentum % | -61.7 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.2 | |||||
Quick Ratio | 3.65 | |||||
Cash Ratio | 3.11 | |||||
Days Inventory | 618.53 | |||||
Days Sales Outstanding | 64.52 | |||||
Days Payable | 522.13 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -188.7 | |||||
Shareholder Yield % | -98.69 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 12.8 | |||||
Operating Margin % | -2007.74 | |||||
Net Margin % | -1487.54 | |||||
FCF Margin % | -1749.82 | |||||
ROE % | -241.84 | |||||
ROA % | -105.44 | |||||
ROIC % | -979.47 | |||||
3-Year ROIIC % | -118.33 | |||||
ROC (Joel Greenblatt) % | -3769.28 | |||||
ROCE % | -178.37 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.29 | |||||
PB Ratio | 0.42 | |||||
Price-to-Tangible-Book | 0.42 | |||||
EV-to-EBIT | 0.29 | |||||
EV-to-EBITDA | 0.29 | |||||
EV-to-Revenue | -5.73 | |||||
EV-to-Forward-Revenue | 262.62 | |||||
EV-to-FCF | 0.33 | |||||
Price-to-Net-Current-Asset-Value | 0.43 | |||||
Price-to-Net-Cash | 0.68 | |||||
Earnings Yield (Greenblatt) % | 344.83 | |||||
FCF Yield % | -352.51 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Helius Medical Technologies Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.55 | ||
EPS (TTM) (€) | -5.144 | ||
Beta | 0 | ||
Volatility % | 45.76 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0 | ||
20-Day SMA (€) | 5.4 | ||
12-1 Month Momentum % | -61.7 | ||
52-Week Range (€) | 5 - 14 | ||
Shares Outstanding (Mil) | 0.89 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Helius Medical Technologies Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Helius Medical Technologies Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Helius Medical Technologies Inc Frequently Asked Questions
What is Helius Medical Technologies Inc(FRA:26H)'s stock price today?
When is next earnings date of Helius Medical Technologies Inc(FRA:26H)?
Does Helius Medical Technologies Inc(FRA:26H) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |